Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial
Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page
- Check4 days agoChange DetectedAdded extensive Locations entries across CA, CO, FL, IL, KS, MA, MI, MN, NV, NJ, NY, TX, VT, WV, and United Kingdom, and updated the page to Revision 3.3.3. The HHS Vulnerability Disclosure section and the v3.3.2 revision entry were removed.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 was applied, replacing v3.2.0. This update seems to be a versioning change and does not alter the study details, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page has removed a government funding operating status notice that previously informed users about potential data processing delays and NIH operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page content remains the same, with only minor visual/layout adjustments observed in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

- Check90 days agoChange DetectedTaxonomy overhaul toward chemistry-focused topics (alkaloids, heterocyclic compounds, nicotine) with an updated version (v3.1.0), and removal of consumer/food/tobacco product categories (v3.0.2).SummaryDifference2%

Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.